Go to article
Posted by CoV Report on September 21, 2021 9:26 amTags: Categories: US National Stories
A second dose of Johnson & Johnson’s COVID-19 vaccine given about two months after the first increased its effectiveness to 94 percent against symptomatic infection, the company said Tuesday.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus